---
figid: PMC9358267__jdapm-22-277-g005
pmcid: PMC9358267
image_filename: jdapm-22-277-g005.jpg
figure_link: /pmc/articles/PMC9358267/figure/F5/
number: Fig. 5
figure_title: 'Phosphorylation of NF-κB following co-treatment of WISH cells with
  DEX and LPS was evaluated using western blot analysis. Relative amounts of phospho-NF-κB
  protein were analyzed by triplicate experiments and normalized to that of NF-κB.
  #P < 0.05 versus control group; *P < 0.05, **P < 0.01 versus LPS group. DEX, dexmedetomidine;
  LPS, lipopolysaccharide; NF-κB, nuclear factor kappa B'
caption: 'Phosphorylation of NF-κB following co-treatment of WISH cells with DEX and
  LPS was evaluated using western blot analysis. Relative amounts of phospho-NF-κB
  protein were analyzed by triplicate experiments and normalized to that of NF-κB.
  #P < 0.05 versus control group; *P < 0.05, **P < 0.01 versus LPS group. DEX, dexmedetomidine;
  LPS, lipopolysaccharide; NF-κB, nuclear factor kappa B.'
article_title: Dexmedetomidine and LPS co-treatment attenuates inflammatory response
  on WISH cells via inhibition of p38/NF-κB signaling pathway.
citation: Tae-Sung Kim, et al. J Dent Anesth Pain Med. 2022 Aug;22(4):277-287.
year: '2022'

doi: 10.17245/jdapm.2022.22.4.277
journal_title: Journal of Dental Anesthesia and Pain Medicine
journal_nlm_ta: J Dent Anesth Pain Med
publisher_name: The Korean Dental Society of Anesthsiology

keywords:
- Cyclooxygenase 2 Inhibitors
- Dexmedetomidine
- Lipopolysaccharides
- Prostaglandin E2
- WISH Cells

---
